NL-OMON34203撤回4 期
Consortium for the Lifespan Examination of ADHD Registry (CLEAR) Study: An International, Longitudinal, Observational Study of Individuals with Attention-Deficit/Hyperactivity Disorder (ADHD) - CLEAR
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 发起方
- Shire
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients meeting all of the criteria listed below at the time of consent may be included in the study:
- •1. Documented diagnosis of ADHD by a physician/clinician.
- •2. Age 18 years or older.
- •3. Read, comprehend, and speak the native language of the country in which they reside.
- •4. An understanding, ability, and willingness to participate in the study and comply with the requirements of the
- •5. Ability to provide written, signed, and dated (personally) informed consent to participate in the study.
排除标准
- •Patients are excluded from the study if any of the following criteria are met at screening/enrollment:
- •1. Life expectancy less than 12 months.
- •2. Currently enrolled in an ADHD clinical trial.
研究者
相似试验
已完成
不适用
ooking into the eye of ADHD. Investigating the relationship between ADHD, the delayed circadian rhythm and the functioning of the eye.Attention-deficit/hyperactivity disorder (ADHD)eye functioning1004751810009841NL-OMON55884Parnassia Bavo Groep (Den Haag)41
进行中（未招募）
1 期
ooking into the eye of ADHD.EUCTR2013-005017-12-NLParnassia Bavo Groep - PsyQ150
进行中（未招募）
不适用
Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy.A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving opioid maintenance therapyPatients will be recruited from out-patient clinics treating opioid dependent patients with buprenorphine or methadone maintenance therapy. Patients will be screened for ADHD symptoms. Based on the screen results, patients will undergo medical and psychiatric assessment to identify those meeting the criteria for adult ADHD. Patients diagnosed with comorbid ADHD and opioid dependence will then be randomized into atomoxetine and placebo study groups.MedDRA version: 12.1Level: LLTClassification code 10064104Term: ADHDEUCTR2010-019981-94-FIHUS/ Neuropsykiatrian poliklinikka30
招募中
不适用
Clinical record investigation about ADHD children before and after the emergency declaration because of COVID19Attention-Deficit/Hyperactivity Disorder: AD/HDJPRN-UMIN000040476Chiba University10
已完成
1 期
erofeeback Training (NFT) of ADHD child at homeADHDADHD hyperactiveD046650JPRN-jRCT1030220201Tazaki Miyako8